Jane Street’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$817K Buy
1,180,081
+501,621
+74% +$370K ﹤0.01% 6937
2025
Q4
$483K Buy
678,460
+522,205
+334% +$710K ﹤0.01% 7763
2025
Q3
$253K Sell
156,255
-219,813
-58% -$221K ﹤0.01% 9236
2025
Q2
$230K Buy
376,068
+357,801
+1,959% +$182K ﹤0.01% 8321
2025
Q1
$10.4K Sell
18,267
-6,872
-27% -$6.78K ﹤0.01% 9201
2024
Q4
$35.9K Sell
25,139
-5,667
-18% -$12.7K ﹤0.01% 9047
2024
Q3
$59.5K Sell
30,806
-33,479
-52% -$94.5K ﹤0.01% 9139
2024
Q2
$199K Buy
64,285
+3,487
+6% +$14.4K ﹤0.01% 8389
2024
Q1
$318K Buy
60,798
+45,357
+294% +$217K ﹤0.01% 7465
2023
Q4
$50K Sell
15,441
-4,559
-23% -$9.84K ﹤0.01% 8779
2023
Q3
$51K Sell
20,000
-71,776
-78% -$300K ﹤0.01% 8151
2023
Q2
$539K Buy
+91,776
New +$533K ﹤0.01% 6202
2023
Q1
Sell
-12,501
Closed -$25.1K 9934
2022
Q4
$25.1K Buy
+12,501
New +$30.5K ﹤0.01% 8550

Other funds holding TNYA

Jane Street's TNYA Position: Q1 2026 in Review

Jane Street increased its Tenaya Therapeutics (TNYA) stake by 74% in Q1 2026, buying an estimated $370K and bringing the position to 1,180,081 shares worth $817K. The position accounts for ﹤0.01% of the portfolio, ranked #6937.

Jane Street first reported a position in TNYA in Q4 2022 and has held it in 13 quarters since. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Jane Street held 1,180,081 shares of Tenaya Therapeutics worth $817K as of Q1 2026.
  • Jane Street bought 501,621 Tenaya Therapeutics shares in Q1 2026, an estimated $370K.
  • Tenaya Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6937 holding.
  • Jane Street first reported a position in Tenaya Therapeutics in Q4 2022 and has held it in 13 quarters since.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.